Latest News
January 22, 2019
HBV, HCV, HIV testing of new cancer patients advised
January 22, 2019
Oncology Practice
January 22, 2019
Age may dictate benefit of andecaliximab in gastric cancer
January 22, 2019
Oncology Practice
January 22, 2019
AML, myeloma risk higher for breast cancer survivors
January 22, 2019
Oncology Practice
January 22, 2019
COLOPEC: Adjuvant HIPEC for high-risk colon cancer disappoints
January 22, 2019
Oncology Practice
Hem-Onc Board Review
Clinical Reviews
January 23, 2019
Aplastic Anemia: Current Treatment
January 23, 2019
Hospital Physician: Hematology/Oncology
January 18, 2019
Aplastic Anemia: Evaluation and Diagnosis
January 18, 2019
Hospital Physician: Hematology/Oncology
October 1, 2018
Management of Metastatic Gastric Cancer
October 1, 2018
Hospital Physician: Hematology/Oncology
Conference Coverage
January 22, 2019
Age may dictate benefit of andecaliximab in gastric cancer
January 22, 2019
Oncology Practice
January 22, 2019
COLOPEC: Adjuvant HIPEC for high-risk colon cancer disappoints
January 22, 2019
Oncology Practice
January 18, 2019
Long-term mogamulizumab appears safe, effective in CTCL
January 18, 2019
Hematology Times
Conference Coverage Videos
January 19, 2019
Four-drug combo shows durable responses in relapsed/refractory lymphomas
January 19, 2019
Hematology Times
December 19, 2018
CLL at ASH: A ‘mountain of data’ for targeted therapies
December 19, 2018
Hematology News
December 17, 2018
Data underscore the importance of lifestyle interventions in breast cancer patients
December 17, 2018
Oncology Practice
December 14, 2018
Extended AI therapy reduces breast cancer recurrence risk, ups fracture risk
December 14, 2018
Oncology Practice
Business of Medicine
January 22, 2019
Revised ACA premium calculator could up uninsured rate
January 22, 2019
Hematology News
January 18, 2019
Cyberbullied by anti-vaxxers: Monique Tello Part I
January 18, 2019
Hematology News
FDA/CDC
January 18, 2019
Zanubrutinib receives breakthrough designation for MCL
January 18, 2019
Hematology News
January 15, 2019
FDA approves cabozantinib for previously treated HCC
January 15, 2019
Oncology Practice
January 9, 2019
Sickle cell infusion gains FDA breakthrough designation
January 9, 2019
Hematology News
Perspectives
January 9, 2019
Gout’s Golden Globe, resistance is fecal, eucalyptus eulogy
January 9, 2019
Hematology News
January 3, 2019
Putting up with abusive patients? That’s not for me.
January 3, 2019
Hematology News
Hematology
January 22, 2019
Matched transplant improves stroke risk indicator in sickle cell anemia
January 22, 2019
Hematology News
January 9, 2019
Plerixafor produced dramatic responses in severe WHIM syndrome
January 9, 2019
Hematology News
January 9, 2019
Sickle cell infusion gains FDA breakthrough designation
January 9, 2019
Hematology News
January 7, 2019
Poor-prognosis cancers linked to highest suicide risk in first year
January 7, 2019
Oncology Practice
Follicular Lymphoma
January 16, 2019
Study supports need for less toxic therapies in FL
January 16, 2019
Oncology Practice
December 6, 2018
Emerging biosimilars market presents opportunities and challenges
December 6, 2018
The Journal of Community and Supportive Oncology
December 5, 2018
Phase 3 study confirms biosimilarity of PF-05280586 with rituximab
December 5, 2018
Oncology Practice
Breast Cancer
January 22, 2019
AML, myeloma risk higher for breast cancer survivors
January 22, 2019
Oncology Practice
January 16, 2019
High postpartum breast cancer metastasis risk may persist for a decade
January 16, 2019
Oncology Practice